NCT00143676
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Birmingham, Alabama, United States
- Northport, Alabama, United States
- Sierra Vista, Arizona, United States
- Tucson, Arizona, United States
Clinical trial condition
Hyperlipidemias
Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.
691 public trials
57 recruiting studies
Hyperlipidemias trial results
NCT00249912
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Birmingham, Alabama, United States
- Haleyville, Alabama, United States
- Mobile, Alabama, United States
- Scottsdale, Arizona, United States
NCT00864643
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
NCT00286481
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Huntsville, Alabama, United States
- Chandler, Arizona, United States
- Scottsdale, Arizona, United States
- Sierra Vista, Arizona, United States
NCT00868127
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
Completed
Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol
NCT00143663
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Northport, Alabama, United States
- Mesa, Arizona, United States
- Chula Vista, California, United States
- Encinitas, California, United States
Completed
A Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability)
NCT01152073
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Mitchell Karl, M.D. -- Cardiology Boca Raton, Florida, United States
NCT00138762
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Mesa, Arizona, United States
- Pfizer Investigational Site Oro Valley, Arizona, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
NCT01365663
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Nuvisan GmbH Neu-Ulm, Germany
NCT01239004
- Conditions
- Dyslipidemia, Dyslipidemias, Glucose Metabolism Disorders, +6 more
- Locations
-
- Radiant Research Chicago, Illinois, United States
- Kansas City, Kansas, United States
- Minneapolis, Minnesota, United States
- St Louis, Missouri, United States